180 related articles for article (PubMed ID: 22020697)
1. Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
Tjon Pian Gi RE; Dietz A; Djukic V; Eckel HE; Friedrich G; Golusinski W; Hantzakos A; Lawson G; Remacle M; Rihkanen H; Dikkers FG
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):361-2. PubMed ID: 22020697
[No Abstract] [Full Text] [Related]
2. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Tjon Pian Gi RE; Ilmarinen T; van den Heuvel ER; Aaltonen LM; Andersen J; Brunings JW; Chirila M; Dietz A; Ferran Vilà F; Friedrich G; de Gier HH; Golusinski W; Graupp M; Hantzakos A; Horcasitas R; Jackowska J; Koelmel JC; Lawson G; Lindner F; Remacle M; Sittel C; Weichbold V; Wierzbicka M; Dikkers FG
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1679-87. PubMed ID: 23377227
[TBL] [Abstract][Full Text] [Related]
3. Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
Derkay CS; Volsky PG; Rosen CA; Pransky SM; McMurray JS; Chadha NK; Froehlich P
Laryngoscope; 2013 Mar; 123(3):705-12. PubMed ID: 23070868
[TBL] [Abstract][Full Text] [Related]
4. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
Donne AJ; Hampson L; He XT; Day PJ; Salway F; Rothera MP; Homer JJ; Hampson IN
Antivir Ther; 2009; 14(7):939-52. PubMed ID: 19918098
[TBL] [Abstract][Full Text] [Related]
5. Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis.
Ksiazek J; Prager JD; Sun GH; Wood RE; Arjmand EM
Otolaryngol Head Neck Surg; 2011 Apr; 144(4):639-41. PubMed ID: 21493248
[TBL] [Abstract][Full Text] [Related]
6. Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.
Grasso M; Remacle M; Bachy V; Van Der Vorst S; Lawson G
Eur Arch Otorhinolaryngol; 2014 Nov; 271(11):2983-90. PubMed ID: 24756616
[TBL] [Abstract][Full Text] [Related]
7. Letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Dikkers FG
Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1789. PubMed ID: 24012217
[No Abstract] [Full Text] [Related]
8. Response to Dikkers letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Clamp PJ; Saunders MW
Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1789. PubMed ID: 24021212
[No Abstract] [Full Text] [Related]
9. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
Shehab N; Sweet BV; Hogikyan ND
Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
[TBL] [Abstract][Full Text] [Related]
11. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.
Milczuk HA
Otolaryngol Head Neck Surg; 2003 Jun; 128(6):788-94. PubMed ID: 12825028
[TBL] [Abstract][Full Text] [Related]
12. Current treatment for laryngeal papillomatosis.
Kendall KA
Curr Opin Otolaryngol Head Neck Surg; 2004 Jun; 12(3):157-9. PubMed ID: 15167022
[No Abstract] [Full Text] [Related]
13. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
[TBL] [Abstract][Full Text] [Related]
14. Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.
Graupp M; Gugatschka M; Kiesler K; Reckenzaun E; Hammer G; Friedrich G
Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):641-6. PubMed ID: 23070260
[TBL] [Abstract][Full Text] [Related]
15. Mucosal bridge and pitting of the true vocal fold: an unusual complication of cidofovir injection.
Man LX; Statham MM; Rosen CA
Ann Otol Rhinol Laryngol; 2010 Apr; 119(4):236-8. PubMed ID: 20433022
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis.
Clamp PJ; Saunders MW
Int J Pediatr Otorhinolaryngol; 2013 Mar; 77(3):323-8. PubMed ID: 23369614
[TBL] [Abstract][Full Text] [Related]
17. In reference to Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
Preuss SF; Quante G
Laryngoscope; 2010 Mar; 120(3):650; author reply 651. PubMed ID: 20013845
[No Abstract] [Full Text] [Related]
18. Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
Durvasula VS; Richter GT
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1912-5. PubMed ID: 24063771
[TBL] [Abstract][Full Text] [Related]
19. Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections.
Naiman AN; Abedipour D; Ayari S; Fresnel E; Coulombeau B; Bour JB; Froehlich P
Ann Otol Rhinol Laryngol; 2006 Mar; 115(3):175-81. PubMed ID: 16572605
[TBL] [Abstract][Full Text] [Related]
20. Novel method of intralesional cidofovir injection into laryngotracheal papillomata.
Sahota RS; Uddin FJ; Al-Shukri J; Moir AA
J Laryngol Otol; 2011 Apr; 125(4):402-4. PubMed ID: 21281536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
